![]() |
市場調査レポート
商品コード
1380388
ソフトジェルカプセルの世界市場:2023-2030年Global Softgel Capsule Market 2023-2030 |
||||||
カスタマイズ可能
|
ソフトジェルカプセルの世界市場:2023-2030年 |
出版日: 2023年09月27日
発行: Orion Market Research
ページ情報: 英文 115 Pages
納期: 2~3営業日
|
世界のソフトジェルカプセル市場は、ソフトジェルカプセルの利点、栄養補助食品や栄養補助食品への需要の増加、天然由来成分への需要の高まり、胃に届いてから数分以内に溶ける消化の良さなどから、予測期間中にCAGR 6.2%の大幅な成長が見込まれています。滑らかなテクスチャーなので、摂取はいつも簡単です。錠剤やカプレットなどの錠剤よりも、飲み込みやすいです。匂いや風味が苦手な懸濁液も、ソフトゼラチンカプセルの剤形であれば簡単に摂取でき、整然とした外観と適切な摂取を提供することができます。
用途別では、栄養補助食品サブセグメントが市場のかなりのシェアを占めると予想され、さらに予測期間中にかなりのCAGRで成長すると予測されます。変形性関節症の増加により、炎症の影響に対抗するためのハーブを使った栄養補助食品の需要が高まっています。さらに、健康とパーソナルケアに関する意識の高まりとZ世代と呼ばれる人口集団が、栄養補助食品とサプリメントの需要を促進しています。世界の栄養補助食品・サプリメント市場は過去10年間で着実に成長しており、2019年にはほぼ3,530億米ドル規模になると報告されています。パンデミック前の米国では、2019年の栄養補助食品の売上高は前年比5%(3億4,500万米ドル)増加しました。栄養補助食品は肥満の解消、美肌効果、がん治療の補助などに効果があります。市場の拡大は、健康とフィットネスの分野によって強化されています。小売業者や生産者は、消費者が健康を重視し続けていることから、栄養補助食品分野における消費者の需要の変化をより認識しています。ビタミンは、錠剤やグミにすると大気中で酸化・劣化しやすいです。したがって、紫外線や酸化から保護され、最終的に保存性が向上するソフトジェルカプセルが最良の製剤オプションとなります。ビタミンは、ソフトジェルカプセルの形で摂取すると、錠剤の形よりも血流への吸収が速くなります。このような利点から、ビタミンは主にソフトジェルカプセルの形で販売されています。
世界のソフトジェルカプセル市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されます。このうち、北米はソフトジェルカプセル製品のサプライヤーが多数存在するため、世界のソフトジェルカプセル市場で大きなシェアを占めています。さらに、製品ポートフォリオを拡大するために、同国の既存企業による研究開発活動が活発化していることが、米国のソフトジェルカプセル世界市場の成長をさらに促進します。
すべての地域の中で、アジア太平洋地域は予測期間中、世界的に顕著なCAGRで成長すると予想されています。その主な理由は、中国とインドにおけるジェネリック医薬品メーカーの巨大な存在感、コスト効率の高い治療薬に対する需要の増加、これらの国々の人口の多さ、経済状況の急速な改善などです。さらに、同地域内での製造受託機関の増加も、高成長の要因となっています。中国の製薬企業の2021年の事業収入は前年比18.7%増となり、過去5年間で最高の成長率を記録しました。この分野の企業は2021年に合わせて5,020億米ドルを稼ぎ出しました。この地域市場の拡大は、アジアの科学的基盤や能力の拡大、アジアの医薬品市場や医薬品製造能力の拡大、アジア太平洋諸国の多くの患者プールによって推進されています。数多くの国際的製薬企業がアジア太平洋地域に生産施設を建設したり、現在の施設を拡張したりしているのは、同地域の巨大な成長ポテンシャルと低い製造コストのためです。
Title: Global Softgel Capsule Market Size, Share & Trends Analysis Report by Material Type (Animal Based and Non-Animal based), by Application (Pharmaceuticals, Nutraceutical and Dietary Supplements and Cosmetics & Personal Care) and By Category (Brand manufacturer and Contract Manufacturer),Forecast Period (2023-2030).
The global softgel capsule market is anticipated to grow at a considerable CAGR of 6.2% during the forecast period owing to benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, rising demand for naturally sourced ingredients and have the quality of easy digest dissolving within a few minutes of reaching the stomach. Consuming is always easy as they have a smooth texture. They are more accessible to gulp down than tablets, caplets, and other pills. Suspensions with an unlikable smell or flavor can be easily ingested in a soft gelatin capsule dosage form, offering an orderly exterior and suitable ingestion.
The global softgel capsule market is segmented on the basis of material type, application and category. Based on the material type, the market is sub-segmented into animal based and non-animal based. Based on the application, the market is sub-segmented into pharmaceuticals, nutraceutical and dietary supplements and cosmetics & personal care. Based on the category the market is sub-segmented into brand manufacturer and contract manufacturer. Among the material type, animal based sub-segment is anticipated to hold a considerable share of the market owing to capacity to hold water, higher melting point, and faster production time, low cost and minimizing potential generation of dust during manufacturing and thereby improving the safety of production personnel. Porcine tissues are used to produce a vast majority of softgel capsules, resulting in a bigger market share for this sector.
Among the application, the nutraceutical and dietary supplements sub-segment is expected to hold a considerable share of the market and is further anticipated to grow at a considerable CAGR over the forecast period. Rising incidences of osteoarthritis have augmented the demand for nutraceuticals made of herbs to counter the effects of inflammation. Additionally growing awareness regarding health and personal care and the population group characterized as Gen Z has propelled the demand for nutraceuticals and supplements. The global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth almost $353 billion in 2019. In the US prior to the pandemic, dietary supplement sales increased by 5% ($345 million) in 2019 compared to the previous year. Nutraceutical products are effective in reducing obesity, improving skin, and aiding in the treatment of cancer. The market expansion has been reinforced by the health and fitness sectors. Retailers and producers are more aware of consumers changing demands in the nutraceuticals sector as consumers continue to place a high priority on their health. Vitamins are prone to atmospheric oxidation and degradation when formulated as tablets or gummies. Hence, softgel capsules are the best formulation option, as they offer protection from UV radiation and oxidation, ultimately improving their shelf life. Vitamins, when taken in softgel capsule form, are more rapidly absorbed in the bloodstream than in a tablet form. Owing to such advantages, vitamins are majorly sold in the softgel capsule form.
The global Softgel capsule market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America to hold a significant share of the global softgel capsule market owing to the presence of a large number of suppliers for softgel capsule products. Additionally, the increasing research and development activities by the established players in the country to expand their product portfolio will further propel the growth of the global softgel capsules market in the US.
Among all regions, the Asia-Pacific region is expected to grow at a prominent CAGR over the forecast period, globally. This can be attributed mostly to enormous presence of generic medicine manufacturers in China and India, increasing demand for cost-efficient therapeutics, large population in these countries, and rapidly improving economic conditions. Additionally rise in contract manufacturing organizations within the region, are factors responsible for its high growth. China's pharmaceutical firms saw their combined business revenue climb 18.7% year on year in 2021, the highest growth rate in five years. Companies in this sector together raked in $502 billion in 2021. The expansion of this regional market is being driven by the expanding Asian scientific base and competence, the expansion of the Asian pharmaceutical market and pharmaceutical manufacturing capabilities, and the sizable patient pool in various Asia Pacific nations. Numerous international pharmaceutical firms are building production facilities in the Asia Pacific region or expanding their current facilities because of the region's enormous growth potential and low manufacturing costs.
The major companies serving the Softgel capsule market include: Nitta Gelatin India Ltd, Fuji Capsule Co., Ltd., Aenova Holding GmbH, GELITA AG, ITALGEL S.r.l., Catalent, Inc, Sirio Pharma Co.,Ltd. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2020, Catalent announced the launch of OptiGel DR technology for the formulation and manufacture of enteric release softgels. The technology allows softgel capsules to be formed by combining pectin, a naturally derived polysaccharide, with gelatin, eliminating the need for a separate capsule coating step.